Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors
The SARS-CoV-2 papain-like protease (PLpro) is of interest as an antiviral drug target. Here, the authors synthesize and characterise naphthalene-based inhibitors for PLpro and present the crystal structures of PLpro in its apo state and with the bound inhibitors, which is of interest for further st...
Main Authors: | Jerzy Osipiuk, Saara-Anne Azizi, Steve Dvorkin, Michael Endres, Robert Jedrzejczak, Krysten A. Jones, Soowon Kang, Rahul S. Kathayat, Youngchang Kim, Vladislav G. Lisnyak, Samantha L. Maki, Vlad Nicolaescu, Cooper A. Taylor, Christine Tesar, Yu-An Zhang, Zhiyao Zhou, Glenn Randall, Karolina Michalska, Scott A. Snyder, Bryan C. Dickinson, Andrzej Joachimiak |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-02-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-021-21060-3 |
Similar Items
-
Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU from SARS-CoV-2
by: Youngchang Kim, et al.
Published: (2021-02-01) -
Computer-aided design of bromelain and papain covalent immobilization
by: Bessy Cutiño-Avila, et al.
Published: (2014-01-01) -
Repurposing Known Drugs as Covalent and Non-covalent Inhibitors of the SARS-CoV-2 Papain-Like Protease
by: Pietro Delre, et al.
Published: (2020-11-01) -
Crystal structures of SARS-CoV-2 ADP-ribose phosphatase: from the apo form to ligand complexes
by: Karolina Michalska, et al.
Published: (2020-09-01) -
Papain Covalently Immobilized on Chitosan–Clay Nanocomposite Films: Application in Synthetic and Real White Wine
by: Ilaria Benucci, et al.
Published: (2020-08-01)